How Community-Based Clinical Trials Can Deliver Diverse Patient Engagement

Guidance by the U.S. Food and Drug Administration requires sponsors developing medical products to have a plan for ensuring a clinical trial is diverse, covering multiple ethnicities. This is because diverse representation in clinical studies is crucial to understanding drug safety as there are sex-dependent and inter-racial/ethnic differences in pharmacokinetics/pharmacodynamics that affect an individual’s response to treatment.

With an increased focus on race and ethnicity, the medical community can better understand the differences in drug exposure and/or response and develop more appropriate, population-specific prescribing recommendations.1 How then, do sponsors increase enrollment diversity and enhance access to clinical trials for potential participants?  

From going directly to a patient’s home to facilitating a trial at a local hospital, learn how healthcare professionals promote engagement while ensuring cultural sensitivity.